ArticleJournal of experimental & clinical cancer research : CR2015

Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells.

Anjali Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.